CRCNS: US-French Collaboration: Dopamine modulation of calcium in STDP
CRCNS:美法合作:STDP 中钙的多巴胺调节
基本信息
- 批准号:8837243
- 负责人:
- 金额:$ 16.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-01 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAgonistAlcohol abuseAlgorithmsBehaviorBiochemistryBrainCalciumCalcium ChannelCardiologyChemosensitizationChronicCollaborationsCommunitiesComputer SimulationComputer softwareCorpus striatum structureCyclic AMP-Dependent Protein KinasesDataDendritesDevelopmentDiseaseDopamineDrug abuseElectrophysiology (science)EndocannabinoidsEnvironmentExposure toFrequenciesFutureGlutamatesGoalsHealth PolicyHippocampus (Brain)ImageIn VitroIndividualInstructionInternationalInvestigationIon ChannelLanguageLasersLearningMeasuresMediatingMemoryMental DepressionMicroscopeModelingN-Methyl-D-Aspartate ReceptorsNamesNeuronsNeurosciencesOutcomeParkinson DiseasePathologyPatternPhysiologicalPositioning AttributePostdoctoral FellowPrincipal InvestigatorProtocols documentationRecordsResearchResolutionRoleScanningSignal PathwaySoftware ToolsSourceStructureStudentsSynapsesSynaptic plasticitySystemTestingTimeTouch sensationTrainingTraining and EducationValidationWithdrawaladdictionbasecalcium indicatorcell typedrug of abuseelectrical propertyin vivomodel developmentmodels and simulationmulti-scale modelingneuronal cell bodynovelopen sourcepostsynapticpresynapticprogramsresearch studyresponsesimulationsocialtherapeutic targettwo-photonvoltage clamp
项目摘要
DESCRIPTION (provided by applicant): Synaptic plasticity is the main mechanism allowing storage of memories and underlies adaptive changes in behavior. As in the hippocampus, both LTP and LTD of the Medium Spiny Neurons (MSN), the projection neurons of the striatum, require elevation of intracellular calcium, but the role of calcium is more elusive in the MSN mostly due to the critical role of dopamine in plasticity. Understanding how the interactions between calcium dynamics and dopamine (via PKA) control synaptic plasticity requires a novel, data-driven modeling approach to study calcium dynamics. A tightly knit collaboration between electrophysiology, calcium imaging, calcium dynamics modeling can for the first time provide a unified understanding of mechanism underlying plasticity. The overall goal of this project is to predict the development of synaptic plasticity direction and magnitude from the stimulation parameters that control neuronal calcium dynamics. This goal is achieved through the following aims: Aim 1: Test the hypothesis that dopamine, via PKA, increases the difference between NMDA receptor mediated and VDCC mediated calcium influx. Aim 2: Investigate how the PKA mediated change in calcium influx through NMDA receptor and CaL channels alters synaptic plasticity. Aim 3: Demonstrate that synaptic plasticity rules can explain in vivo synaptic plasticiy, and the change in plasticity caused by the dopamine depletion of Parkinson's Disease. The aims are achieved through cycles of model development and prediction followed by electrophysiology and calcium imaging experiments. The proposed research, as well as future investigations of the calcium dynamics in other cell types, is enabled by development and integration of software for parameter optimization with multi-compartmental, multi-ion channel neuron models of realistic calcium dynamics. Demonstrating a relationship between calcium dynamics and striatal synaptic plasticity has implications far beyond striatal plasticity. Modeling
the complexity of calcium handling in neurons will expand the range of cell types and stimulation protocols that can be correlated with synaptic plasticity outcomes. The key role of dopamine in several devastating neuronal disorders places dopamine as a central issue from the perspective of health policies, and it is likely that the study of the dopaminergic control of plasticity inducion will contribute to the understanding of several pathologies and to the identification of original therapeutic targets. Changes in synaptic plasticity due to Parkinson's and addiction are partly due to the dopamine mediated changes in NMDA receptor composition and calcium influx. Exposure to and withdrawal from drugs of abuse cause alteration in NMDA receptors and synaptic plasticity. Thus understanding the interaction between calcium and dopamine in striatal synaptic plasticity will illuminate mechanisms underlying normal memory storage, and also the abnormal plasticity observed in Parkinson's disease, and chronic drug and alcohol abuse. Moreover, dopamine exerts a major influence on the general motivational organization of behavior. Uncovering the action of dopamine thus reaches further than the understanding of aspects of brain functions, as it may touch on the organization of individuals within social structures. The broader impacts include development of software tools and cross-disciplinary education and training. The multi-scale modeling software tools will be made available (in open source form) to the community. This software is broadly applicable not only to address major questions in neuroscience, but also to other physiological systems, such as cardiology where signaling pathways interact with electrical properties. More importantly, the modeling software employs a declarative language with parameter names taken from biochemistry, such that the software is intuitive for experimentalists to learn. This project will provide a uniquely cross-disciplinary environment for training students and post-doctoral fellows. The trainees from this program will be uniquely positioned to develop the field of data driven modeling of signaling pathways. The PIs have extensive track records of international cross-disciplinary instruction, with tutorial material on modeling signaling pathways made publicly available.
描述(由申请人提供):突触可塑性是允许存储记忆的主要机制,是行为适应性变化的基础。在海马体中,中棘神经元(MSN)(纹状体的投射神经元)的LTP和LTD都需要细胞内钙的升高,但钙在MSN中的作用更难以捉摸,主要是由于多巴胺在可塑性中的关键作用。了解钙动力学和多巴胺(通过PKA)之间的相互作用如何控制突触可塑性需要一种新的,数据驱动的建模方法来研究钙动力学。电生理学、钙成像、钙动力学模型之间的紧密合作可以首次提供对可塑性机制的统一理解。本项目的总体目标是从控制神经元钙动力学的刺激参数预测突触可塑性发展的方向和幅度。目的1:验证多巴胺通过PKA增加NMDA受体介导的和VDCC介导的钙内流之间的差异的假设。目的2:研究PKA介导的NMDA受体和CaL通道钙内流的变化对突触可塑性的影响。目标三:证明突触可塑性规则可以解释体内突触可塑性,以及帕金森氏病多巴胺耗竭引起的可塑性变化。这些目标是通过模型开发和预测的循环,然后是电生理学和钙成像实验来实现的。所提出的研究,以及其他细胞类型的钙动力学的未来调查,是通过开发和集成的软件参数优化与多房室,多离子通道神经元模型的现实钙动力学。证明钙动力学和纹状体突触可塑性之间的关系的影响远远超出了纹状体可塑性。建模
神经元中钙处理的复杂性将扩大可与突触可塑性结果相关的细胞类型和刺激方案的范围。多巴胺在几种破坏性神经元疾病中的关键作用使多巴胺成为卫生政策的核心问题,并且很可能多巴胺能控制可塑性诱导的研究将有助于理解几种病理学和识别原始治疗靶点。帕金森病和成瘾引起的突触可塑性变化部分是由于多巴胺介导的NMDA受体组成和钙内流的变化。暴露于滥用药物和从滥用药物中戒断引起NMDA受体和突触可塑性的改变。因此,了解纹状体突触可塑性中钙和多巴胺之间的相互作用将阐明正常记忆储存的机制,以及在帕金森病和慢性药物和酒精滥用中观察到的异常可塑性。此外,多巴胺对行为的一般动机组织产生重大影响。因此,揭示多巴胺的作用比理解大脑功能的各个方面更深入,因为它可能触及社会结构中的个体组织。更广泛的影响包括开发软件工具和跨学科教育和培训。多尺度建模软件工具将(以开源形式)提供给社区。该软件不仅广泛适用于解决神经科学中的主要问题,而且还适用于其他生理系统,例如信号通路与电特性相互作用的心脏病学。更重要的是,建模软件采用了一种声明性语言,其参数名称取自生物化学,因此该软件对于实验人员来说是直观的。该项目将为培养学生和博士后研究员提供一个独特的跨学科环境。来自该计划的学员将处于独特的地位,以发展信号通路的数据驱动建模领域。PI在国际跨学科教学方面有着广泛的记录,并公开了关于建模信号通路的教程材料。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kim L Blackwell其他文献
Kim L Blackwell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kim L Blackwell', 18)}}的其他基金
Estradiol signaling pathways mediating sex differences in striatal synaptic plasticity
雌二醇信号通路介导纹状体突触可塑性的性别差异
- 批准号:
10607187 - 财政年份:2023
- 资助金额:
$ 16.98万 - 项目类别:
CRCNS: US-French Collaboration: Dopamine modulation of calcium in STDP
CRCNS:美法合作:STDP 中钙的多巴胺调节
- 批准号:
9330134 - 财政年份:2014
- 资助金额:
$ 16.98万 - 项目类别:
CRCNS: Spatio-temporal Dynamics Dopamine Activated Path
CRCNS:时空动力学多巴胺激活路径
- 批准号:
7047332 - 财政年份:2005
- 资助金额:
$ 16.98万 - 项目类别:
CRCNS: Spatio-temporal Dynamics of Dopamine Activated 2nd Messenger Pathway
CRCNS:多巴胺激活的第二信使通路的时空动力学
- 批准号:
8437354 - 财政年份:2005
- 资助金额:
$ 16.98万 - 项目类别:
CRCNS: Spatio-temporal Dynamics of Dopamine Activated 2nd Messenger Pathway
CRCNS:多巴胺激活的第二信使通路的时空动力学
- 批准号:
9298372 - 财政年份:2005
- 资助金额:
$ 16.98万 - 项目类别:
CRCNS: Spatio-temporal Dynamics of Dopamine Activated 2nd Messenger Pathway
CRCNS:多巴胺激活的第二信使通路的时空动力学
- 批准号:
9100600 - 财政年份:2005
- 资助金额:
$ 16.98万 - 项目类别:
CRCNS: Spatio-temporal Dynamics of Dopamine Activated 2nd Messenger Pathways
CRCNS:多巴胺激活的第二信使通路的时空动力学
- 批准号:
7425893 - 财政年份:2005
- 资助金额:
$ 16.98万 - 项目类别:
CRCNS: Spatio-temporal Dynamics of Dopamine Activated 2nd Messenger Pathway
CRCNS:多巴胺激活的第二信使通路的时空动力学
- 批准号:
8690685 - 财政年份:2005
- 资助金额:
$ 16.98万 - 项目类别:
CRCNS: Spatio-temporal Dynamics of Dopamine Activated 2nd Messenger Pathways
CRCNS:多巴胺激活的第二信使通路的时空动力学
- 批准号:
7116994 - 财政年份:2005
- 资助金额:
$ 16.98万 - 项目类别:
CRCNS: Spatio-temporal Dynamics of Dopamine Activated 2nd Messenger Pathways
CRCNS:多巴胺激活的第二信使通路的时空动力学
- 批准号:
7237931 - 财政年份:2005
- 资助金额:
$ 16.98万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 16.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 16.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 16.98万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 16.98万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 16.98万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 16.98万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 16.98万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 16.98万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 16.98万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 16.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)